Influence of GABA and GABA-like drugs on monoaminergic mechanisms.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D001679:Biogenic Amines / Q000502:physiology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006885:Hydroxybutyrates / Q000494:pharmacology; D007276:Injections, Intraventricular; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013373:Substance P / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000494:pharmacology*
D000613:Aminobutyrates; D001679:Biogenic Amines; D006885:Hydroxybutyrates; D011955:Receptors, Drug; D012701:Serotonin; D013373:Substance P; D005680:gamma-Aminobutyric Acid; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D001418:Baclofen; D004298:Dopamine; D009638:Norepinephrine